Delivery Order SPE2DB22D3301-SPE2DB25FY7FQ

Award Date 7/2/25
Potential Completion Date 7/24/25
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 100 unit vials, with a ceiling value of $1,117.48 and a performance period ending on June 9, 2025. The contract is a firm fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,934.16, is for the delivery of 4,568,096,981 units of XEOMIN 100 unit vials. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of the medication XEOMIN, with a ceiling value of $5,587.40 and a period of performance through July 3, 2025. The contract is a firm-fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 200 unit vials. The contract is a firm fixed-price delivery order with a ceiling value of $6,704.88 and a period of performance through July 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of the medication XEOMIN, with a total ceiling value of $1,117.48. The contract is a Firm Fixed Price arrangement, has no set-aside designation, and is scheduled for completion by June 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,039.40 firm fixed price contract is for the delivery of XEOMIN 50 unit vials and has an ultimate completion date of April 3, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 100 unit vials. The firm-fixed-price contract has a ceiling value of $22,018.08 and a period of performance through November 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the procurement of XEOMIN 200 UNIT VIALS, a pharmaceutical product, with a ceiling value of $5,587.40 and a performance period through February 20, 2025. The contract is a firm fixed-price, delivery order type with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 50 unit vials. The contract has a ceiling value of $1,710.00 and is a firm fixed-price delivery order running through April 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,822.36 firm fixed-price contract is for the delivery of XEOMIN 100 unit vials. The contract has an ultimate completion date of June 17, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY7FQ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of the drug XEOMIN, with a ceiling value of $22,349.60 and a period of performance through July 24, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 10/1/25, 9:46 AM